“Not only is this reform a game-changer for Australian patients, but it truly showcases the Australian Government’s commitment in empowering patients with more knowledge and a better understanding of their medicines. This is of key importance in the current COVID-19 environment,” said GBMA chair Jane Halton AO PSM. …
GBMA's says active ingredient prescribing a 'game-changer' for patients
February 1, 2021 Latest NewsBioPharma
Latest Video
New Stories
-
Major brands and biosimilars feature prominently on November PBAC agenda
July 23, 2026 - - Latest News -
Bellberry and ASCEPT release checklist for 'new approach methodologies' trials
July 23, 2026 - - Latest News -
Faster processes could push Pharmac's options for investment backlog to 400 within two years
July 23, 2026 - - Latest News -
How national HPV vaccination programs are changing the story of cervical cancer
July 23, 2026 - - Latest News -
BLS and Trexapharm move to bring TREXAVIVE to Australian patients
July 22, 2026 - - BioPharma -
Radiopharm Theranostics reports positive results in tumour trials
July 22, 2026 - - Australian Biotech -
Proteomics International and Healius team up to take Promarker tests national
July 22, 2026 - - Australian Biotech